T. Rowe Price Associates
AMAG

T. Rowe Price Associates’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-45,906
Closed -$432K 2752
2020
Q3
$432K Sell
45,906
-116
-0.3% -$1.09K ﹤0.01% 2147
2020
Q2
$352K Sell
46,022
-4,009
-8% -$30.7K ﹤0.01% 2196
2020
Q1
$309K Buy
50,031
+16,110
+47% +$99.5K ﹤0.01% 2180
2019
Q4
$413K Buy
33,921
+1,335
+4% +$16.3K ﹤0.01% 2219
2019
Q3
$376K Buy
32,586
+19,923
+157% +$230K ﹤0.01% 2201
2019
Q2
$127K Buy
12,663
+100
+0.8% +$1K ﹤0.01% 2450
2019
Q1
$162K Sell
12,563
-449,543
-97% -$5.8M ﹤0.01% 2422
2018
Q4
$7.02M Sell
462,106
-6,076
-1% -$92.3K ﹤0.01% 1367
2018
Q3
$9.36M Buy
468,182
+4,521
+1% +$90.4K ﹤0.01% 1386
2018
Q2
$9.04M Buy
463,661
+196,249
+73% +$3.83M ﹤0.01% 1364
2018
Q1
$5.39M Buy
267,412
+69,253
+35% +$1.4M ﹤0.01% 1418
2017
Q4
$2.63M Buy
198,159
+1,573
+0.8% +$20.8K ﹤0.01% 1505
2017
Q3
$3.63M Sell
196,586
-10,236
-5% -$189K ﹤0.01% 1458
2017
Q2
$3.81M Sell
206,822
-11,898
-5% -$219K ﹤0.01% 1444
2017
Q1
$4.93M Buy
218,720
+7,220
+3% +$163K ﹤0.01% 1432
2016
Q4
$7.36M Buy
211,500
+9,310
+5% +$324K ﹤0.01% 1364
2016
Q3
$4.96M Sell
202,190
-331,310
-62% -$8.12M ﹤0.01% 1428
2016
Q2
$12.8M Buy
533,500
+13,120
+3% +$314K ﹤0.01% 1237
2016
Q1
$12.2M Sell
520,380
-9,980
-2% -$234K ﹤0.01% 1226
2015
Q4
$16M Buy
530,360
+22,800
+4% +$688K ﹤0.01% 1154
2015
Q3
$20.2M Buy
507,560
+43,090
+9% +$1.71M ﹤0.01% 1085
2015
Q2
$32.1M Buy
464,470
+27,200
+6% +$1.88M 0.01% 986
2015
Q1
$23.9M Buy
437,270
+4,300
+1% +$235K ﹤0.01% 1069
2014
Q4
$18.5M Buy
432,970
+6,850
+2% +$292K ﹤0.01% 1137
2014
Q3
$13.6M Buy
426,120
+900
+0.2% +$28.7K ﹤0.01% 1222
2014
Q2
$8.81M Sell
425,220
-995,900
-70% -$20.6M ﹤0.01% 1344
2014
Q1
$27.5M Sell
1,421,120
-233,900
-14% -$4.53M 0.01% 1032
2013
Q4
$40.2M Sell
1,655,020
-444,302
-21% -$10.8M 0.01% 905
2013
Q3
$45.1M Buy
2,099,322
+59,922
+3% +$1.29M 0.01% 849
2013
Q2
$45.4M Buy
+2,039,400
New +$45.4M 0.01% 821